The company takes stock of the work in the first quarter and puts forward the work requirements for the second quarter.
Release time:
2020-08-14
Company Counts Work in the First Quarter and Proposes Work Requirements for the Second Quarter
News 4# July 17 and 18 , the Company successively held work analysis meetings for cement sector, pharmaceutical industry, international trade and cable companies to summarize the gains and losses of the work in the first quarter and put forward requirements for the next stage, especially the work in the second quarter. At the
analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter in the form of PPT , focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements.
Cement Plate: Optimize Structure, Improve Efficiency, Insist on Maximizing Benefits
In the first quarter, the overall benefits of the two peak cement enterprises increased year on year. Removing the factor of rising coal prices, various production indicators such as kiln production, cement mill production and power consumption per ton of clinker were improved, and the optimization of management organizations and posts was also steadily advancing. The company leaders pointed out that the future competition in the cement industry will be more cruel. Jianfeng Cement must clarify its thinking, seize the current more favorable opportunity, strengthen its own strength, adhere to the principle of maximizing benefits, strengthen the construction of core profit areas, and strive to achieve a balance of production and sales while striving for Greater profit space. The
meeting required the two cement companies to adjust the balance between the product structure and the target market in terms of sales according to the actual situation of the company and the development trend of the cement industry in the region, so as to improve the comprehensive gross profit and lay a good foundation for the continued stability of the market in the future. In terms of internal management, while strengthening the optimization of institutions and posts, carefully sort out and improve the functions and responsibilities of departments, teams and posts, and standardize the work process and work standards in detail; combine internal training with external training, strengthen the training of employees' knowledge of cement production technology and equipment, and comprehensively improve the overall quality of employees; strengthen equipment maintenance and management, equipment maintenance standards, procurement and storage of spare parts, and equipment replacement cycles must be strictly and scientifically controlled, and problems must be deeply summarized to effectively improve the reliability and stability of equipment operation; strengthen technical research and technological transformation, and continue to introduce And use new technologies to further optimize and improve various production indicators; improve the implementation of responsibilities and evaluation incentive mechanisms, ensure that every control index and the requirements of every production link can be consciously implemented in the post, so that the work is consistent with the evaluation and assessment, and the enthusiasm of the whole staff is improved. In terms of environmental protection and safety management, it is necessary to eliminate fluke mentality, earnestly implement the safety and environmental protection responsibility system at all levels, increase investment in related facilities, equipment and technical transformation, strengthen self-inspection and self-correction of habitual violations, and earnestly implement the hazardous environment operation ticket system. Optimize the actual situation and revise and improve the safety work procedures to ensure safe and orderly production.
According to the specific conditions of the two enterprises, the company leaders also requested Daye Peak to further strengthen daily inspection and maintenance to avoid overload operation of equipment and reduce unstable factors affecting production. Yunnan Peak should adjust its sales strategy in rainy season in advance to ensure the balance of production and sales and market stability.
Peak Pharmaceutical Industry: Finding Gaps, Setting Benchmarks, Brave Innovation, Seeking Breakthrough
With the further deepening of medical system reform, drug consistency evaluation and the implementation of the "two-vote system", the production and operation of pharmaceutical enterprises are facing many new pressures. At the analysis meeting, the company leaders asked the pharmaceutical company to recognize the policy changes and the development trend of the industry, seriously think about the future work with a higher height, wider vision and longer-term vision, deeply analyze the gap with the advanced enterprises in the same industry, select the benchmark, solve their own shortcomings and problems point to point, and seek breakthroughs.
In terms of sales, we must boldly innovate marketing mechanisms and methods, boldly use talents, give full play to the enthusiasm of sales staff, increase assessment efforts, carry out precise incentives, and seek sales breakthroughs; according to the specific conditions of each product, Do a good job of bidding with the idea of long-term benefit planning to lay the foundation for market expansion and product volume. In terms of production, we should firmly establish the purpose of serving all for sales, pay close attention to cost management on the premise of ensuring quality, and strive to reduce production costs by improving the yield, one-time pass rate and quality rate. In terms of product development, boldly introduce new varieties with market and technical advantages, and accelerate the promotion of consistency evaluation and other related work. In terms of internal management, we should make forward-looking information investment, improve the level of information construction, and improve operational efficiency; boldly employ new people, train, select and enrich the talent team; continue to promote the optimization of internal management structure and team building, and strive to innovate in working ideas and working methods, so as to realize the self-improvement and transformation of the team. In terms of project promotion, accelerate the implementation of international certification, Jinder, artificial bezoar and other work, and pay close attention to and track the operation of Huibaoyuan and other enterprises. The meeting also asked pharmaceutical companies to implement the division of labor and clear responsibilities from the members of the management team, so as to make the whole organizational structure operate more smoothly and efficiently.
International Trade Company: Find the correct positioning and development direction, strengthen management, and improve service quality
Company leadership requirements, international trade companies must clarify the goal and direction of "modern logistics", and combine the actual situation of the company, Carry out various tasks in a targeted manner, form a business model with advantages and own characteristics, and strengthen the construction of a talent team that is compatible with its own positioning; on the existing basis, continue to improve old business, expand new business, and extend the business chain; strengthen internal management, improve management standardization, and improve service quality; strengthen the cultivation of sense of responsibility and mission, reduce management levels, implement precise incentives, and give full play to The enthusiasm of employees; sort out and formulate various systems based on the principles of operability and efficiency, eliminate management loopholes, and reduce operating costs.
Peak Cable: Thrift and Thrift, Maintain Stability
Cable Company's overall production and operation in the first quarter was stable. The company's leaders required the management team to do a good job in the management of assets, personnel, safe production and receivables, organize and carry out various tasks such as procurement, production and sales with the idea of "thrifty and thrifty", strive to reduce production costs and lay a good foundation for future transformation.
The first quarter job analysis meeting of Spike Health Technology will be held at a later date. (Reporter Fu Yiwu)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page